Provided by Tiger Trade Technology Pte. Ltd.

Enanta Pharmaceuticals

12.20
+0.02000.16%
Volume:46.76K
Turnover:567.19K
Market Cap:354.03M
PE:-3.95
High:12.44
Open:12.14
Low:11.75
Close:12.18
52wk High:17.15
52wk Low:4.09
Shares:29.02M
Float Shares:20.83M
Volume Ratio:0.68
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0871
EPS(LYR):-3.8381
ROE:-60.01%
ROA:-13.47%
PB:2.80
PE(LYR):-3.18

Loading ...

Enanta Sues Pfizer in EU Over Paxlovid Patent Infringement

Reuters
·
Nov 18, 2025

Enanta Pharmaceuticals Q4 Operating Expenses USD 33.511 Million

THOMSON REUTERS
·
Nov 18, 2025

Enanta Pharmaceuticals Q4 Operating Income USD -18.386 Million

THOMSON REUTERS
·
Nov 18, 2025

Enanta Pharmaceuticals Q4 Net Income USD -18.7 Million

THOMSON REUTERS
·
Nov 18, 2025

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Fourth Quarter and Year-Ended September 30, 2025

THOMSON REUTERS
·
Nov 18, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 17, 2025

Enanta Pharmaceuticals Initiated at Overweight by JP Morgan

Dow Jones
·
Nov 14, 2025

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14, 2025

Enanta Pharmaceuticals Inc : JP Morgan Initiates Coverage With Overweight Rating; Target Price $17.00

THOMSON REUTERS
·
Nov 14, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Not Doing Enough For Some Investors As Its Shares Slump 30%

Simply Wall St.
·
Oct 30, 2025

Enanta Reports New Data Showing Zelicapavir Shortens RSV Symptoms in Young Children

Reuters
·
Oct 20, 2025

Enanta Pharmaceuticals Announces Positive Clinical Trial Results for Zelicapavir and EDP-323 in RSV Treatment at Upcoming IDWeek 2025

Reuters
·
Oct 07, 2025

BRIEF-Enanta Pharmaceuticals Announces Closing Of Upsized Public Offering Of Common Stock

Reuters
·
Oct 03, 2025

Enanta Pharmaceuticals Closes Stock Offering

MT Newswires Live
·
Oct 03, 2025

Enanta Pharmaceuticals Raises $74.75 Million in Upsized Public Offering of Common Stock

Reuters
·
Oct 03, 2025

Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

THOMSON REUTERS
·
Oct 03, 2025

Enanta Pharmaceuticals Announces Public Stock Offering

TIPRANKS
·
Oct 02, 2025

Enanta Pharmaceuticals Raised to Buy From Hold by Jefferies

Dow Jones
·
Oct 02, 2025

Enanta Pharmaceuticals Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $20 From $14

THOMSON REUTERS
·
Oct 01, 2025

Jefferies Upgrades Enanta Pharmaceuticals to Buy From Hold, $20 Price Target

MT Newswires Live
·
Oct 01, 2025